Approved Symbol |
Approved Name |
Location |
Type |
No. of Association Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
SLC6A2 |
solute carrier family 6 (neurotransmitter transporter), member 2 |
16q12.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
13(4/9/0)
|
TAS[2008212]
|
GJD2 |
gap junction protein delta 2 |
15q13.1 |
rSNP target |
0
|
TAS
|
CHRNA5 |
cholinergic receptor, nicotinic alpha 5 |
15q24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
2(1/1/0)
|
TAS[9009220]
|
CHRNA3 |
cholinergic receptor, nicotinic alpha 3 |
15q24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(0/1/0)
|
TAS
|
GABBR2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
9q22.1-q22.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
TAS
|
CHRNA7 |
cholinergic receptor, nicotinic alpha 7 |
15q13.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(1/0/0)
|
TAS
|
ADCY8 |
adenylate cyclase 8 (brain) |
8q24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
TAS
|
VIPR1 |
vasoactive intestinal peptide receptor 1 |
3p22 |
rSNP target |
0
|
TAS[8390245]
|
GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
9q34.3 |
Literature-origin |
1(0/0/1)
|
TAS
|
COMT |
catechol-O-methyltransferase |
22q11.21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
21(9/12/0)
|
TAS
|
PRKCA |
protein kinase C, alpha |
17q24.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
10(9/0/1)
|
TAS
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
16p13.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
TAS
|
UNC13C |
unc-13 homolog C (C. elegans) |
15q21.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
ISS
|
GRIN2B |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
12p13.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
TAS
|
CHRNA2 |
cholinergic receptor, nicotinic alpha 2 |
8p21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
TAS
|
SLC6A3 |
solute carrier family 6 (neurotransmitter transporter), member 3 |
5p15.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
21(11/10/0)
|
TAS
|
GABRA2 |
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
4p12 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
3(1/2/0)
|
TAS
|
CHRNB3 |
cholinergic receptor, nicotinic beta 3 |
8p11.21 |
Mapped by Literature SNP, Mapped by LD-proxy |
0
|
TAS
|
SLC6A4 |
solute carrier family 6 (neurotransmitter transporter), member 4 |
17q11.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
44(13/31/0)
|
IBA
|
LIN7C |
lin-7 homolog C (C. elegans) |
11p14 |
rSNP target |
0
|
TAS
|
MAOA |
monoamine oxidase A |
Xp11.4-p11.3 |
Literature-origin |
2(0/2/0)
|
TAS
|
CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
12p13.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(0/2/0)
|
IEA
|
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
13q14-q21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
4(2/2/0)
|
TAS[9109547]
|
CHRNB4 |
cholinergic receptor, nicotinic beta 4 |
15q24 |
Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
0
|
TAS
|
NPY |
neuropeptide Y |
7p15.3 |
Literature-origin, Mapped by Literature SNP |
2(0/2/0)
|
TAS[10557353]
|
GABRG3 |
gamma-aminobutyric acid (GABA) A receptor, gamma 3 |
15q12 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
TAS
|
OPRL1 |
opiate receptor-like 1 |
20q13.33 |
Literature-origin, Mapped by Literature SNP |
0
|
IBA
|
SLC18A2 |
solute carrier family 18 (vesicular monoamine transporter), member 2 |
10q25 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
3(2/1/0)
|
TAS[15217342]
|
CHRNA4 |
cholinergic receptor, nicotinic alpha 4 |
20q13.33 |
Literature-origin |
1(1/0/0)
|
NAS[7550350]; TAS
|
DBH |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
9q34 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
4(0/4/0)
|
TAS[2880016]
|
CHRNA6 |
cholinergic receptor, nicotinic alpha 6 |
8p22 |
Literature-origin, Mapped by Literature SNP |
1(0/1/0)
|
TAS
|
KCNC1 |
potassium channel, voltage gated Shaw related subfamily C, member 1 |
11p15 |
rSNP target |
0
|
TAS
|